Sotera Health/$SHC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Sotera Health
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe and other regions.
Ticker
$SHC
Sector
Primary listing
Industry
Life Sciences Tools & Services
Headquarters
Employees
3,000
ISIN
US83601L1026
Website
Sotera Health Metrics
BasicAdvanced
$3.2B
129.84
$0.09
1.89
-
Price and volume
Market cap
$3.2B
Beta
1.89
52-week high
$16.75
52-week low
$9.53
Average daily volume
1.3M
Financial strength
Current ratio
2.456
Quick ratio
2.026
Long term debt to equity
561.34
Total debt to equity
566.879
Interest coverage (TTM)
2.11%
Profitability
EBITDA (TTM)
520.473
Gross margin (TTM)
55.17%
Net profit margin (TTM)
2.24%
Operating margin (TTM)
31.92%
Effective tax rate (TTM)
71.81%
Revenue per employee (TTM)
$370,000
Management effectiveness
Return on assets (TTM)
7.17%
Return on equity (TTM)
5.88%
Valuation
Price to earnings (TTM)
129.837
Price to revenue (TTM)
2.907
Price to book
7.79
Price to tangible book (TTM)
-3.32
Price to free cash flow (TTM)
30.382
Free cash flow yield (TTM)
3.29%
Free cash flow per share (TTM)
37.39%
Growth
Revenue change (TTM)
2.78%
Earnings per share change (TTM)
-53.92%
3-year revenue growth (CAGR)
5.00%
3-year earnings per share growth (CAGR)
-43.31%
What the Analysts think about Sotera Health
Analyst ratings (Buy, Hold, Sell) for Sotera Health stock.
Bulls say / Bears say
Sotera Health reported a 4.9% increase in net revenues to $1.10 billion for the full year 2024, indicating steady growth in its core business operations. (stocktitan.net)
The company projects net revenue growth of 4.0% to 6.0% and adjusted EBITDA growth of 4.5% to 6.5% for 2025, suggesting confidence in continued financial performance. (stocktitan.net)
Citigroup raised its price target for Sotera Health from $18.00 to $20.00, maintaining a 'buy' rating, reflecting positive analyst sentiment. (marketbeat.com)
Barclays lowered its price target for Sotera Health from $16.00 to $12.00, indicating concerns about the company's future performance. (defenseworld.net)
The company reported a 6.5% decrease in net revenues to $290 million in Q4 2024, suggesting potential challenges in maintaining revenue growth. (stocktitan.net)
Sotera Health is facing significant litigation challenges, which could impact its financial stability and investor confidence. (seekingalpha.com)
Data summarised monthly by Lightyear AI. Last updated on 9 Jun 2025.
Sotera Health Financial Performance
Revenues and expenses
Sotera Health Earnings Performance
Company profitability
Sotera Health News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sotera Health stock?
Sotera Health (SHC) has a market cap of $3.2B as of June 27, 2025.
What is the P/E ratio for Sotera Health stock?
The price to earnings (P/E) ratio for Sotera Health (SHC) stock is 129.84 as of June 27, 2025.
Does Sotera Health stock pay dividends?
No, Sotera Health (SHC) stock does not pay dividends to its shareholders as of June 27, 2025.
When is the next Sotera Health dividend payment date?
Sotera Health (SHC) stock does not pay dividends to its shareholders.
What is the beta indicator for Sotera Health?
Sotera Health (SHC) has a beta rating of 1.89. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.